Axsome Therapeutics, Inc.
NASDAQ:AXSM
87.25 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 87.166 | 74.999 | 71.53 | 57.794 | 46.7 | 94.576 | 24.372 | 16.846 | 8.82 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 9.908 | 8.128 | 7.378 | 6.532 | 4.599 | 7.556 | 2.291 | 1.924 | 0.983 | 0.312 | 0.307 | 0.3 | 0.277 | 0.008 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 77.258 | 66.871 | 64.152 | 51.262 | 42.101 | 87.02 | 22.081 | 14.922 | 7.837 | -0.312 | -0.307 | -0.3 | -0.277 | -0.008 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.886 | 0.892 | 0.897 | 0.887 | 0.902 | 0.92 | 0.906 | 0.886 | 0.889 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 49.59 | 36.588 | 30.803 | 28.767 | 20.581 | 17.793 | 14.693 | 14.877 | 15.792 | 12.585 | 13.781 | 13.18 | 14.503 | 16.596 | 17.385 | 14.795 | 10.543 | 27.521 | 19.205 | 15.836 | 11.003 | 7.603 | 7.151 | 6.041 | 5.551 | 4.753 | 4.494 | 4.471 | 5.007 | 5.985 | 5.807 | 5.569 | 5.298 | 4.526 | 2.208 | 1.524 | 1.628 | 1.416 | 1.348 | 1.302 | 0.815 | 0.815 |
| General & Administrative Expenses
| 73.254 | 74.97 | 62.709 | 55.088 | 52.235 | 52.791 | 97.756 | 40.892 | 31.16 | 25.704 | 18.827 | 20.227 | 16.344 | 11.248 | 10.36 | 6.331 | 7.236 | 4.97 | 5.223 | 3.112 | 2.445 | 2.818 | 2.299 | 2.203 | 2.439 | 2.411 | 1.95 | 1.826 | 1.743 | 1.687 | 1.819 | 1.639 | 1.529 | 1.357 | 0.947 | 0.499 | 0.456 | 0.517 | 0.601 | 0.395 | 0.198 | 0.198 |
| Selling & Marketing Expenses
| 30.3 | 24 | 24.1 | 28.1 | 26.7 | 21.4 | -36.259 | 13.8 | 9.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 103.554 | 98.97 | 86.809 | 83.188 | 78.935 | 74.191 | 61.497 | 40.892 | 31.16 | 25.704 | 18.827 | 20.227 | 16.344 | 11.248 | 10.36 | 6.331 | 7.236 | 4.97 | 5.223 | 3.112 | 2.445 | 2.818 | 2.299 | 2.203 | 2.439 | 2.411 | 1.95 | 1.826 | 1.743 | 1.687 | 1.819 | 1.639 | 1.529 | 1.357 | 0.947 | 0.499 | 0.456 | 0.517 | 0.601 | 0.395 | 0.198 | 0.198 |
| Other Expenses
| 3.75 | 0.177 | 50.705 | 1.427 | 7.642 | 1.572 | 1.607 | 1.607 | 0.926 | 0 | 0 | 0 | 0 | 0 | -0.054 | 0 | 0 | 0 | 0.139 | 0.139 | 0 | 0 | 0.217 | 0.217 | 0 | 0 | 0.207 | 0.207 | 0 | 0 | 0.474 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 153.144 | 135.558 | 168.317 | 113.382 | 101.105 | 93.556 | 77.797 | 57.376 | 47.878 | 38.289 | 32.608 | 33.407 | 30.848 | 27.844 | 27.691 | 21.127 | 17.779 | 32.491 | 24.428 | 18.808 | 13.448 | 10.421 | 9.45 | 8.026 | 7.99 | 7.163 | 6.444 | 6.09 | 6.751 | 7.672 | 7.151 | 7.208 | 6.827 | 5.883 | 3.155 | 2.024 | 2.085 | 1.933 | 1.948 | 1.697 | 1.907 | 1.907 |
| Operating Income
| -75.886 | -68.687 | -98.112 | -62.12 | -65.057 | -6.536 | -55.717 | -42.454 | -40.041 | -38.289 | -32.608 | -33.407 | -30.848 | -27.844 | -27.744 | -21.127 | -17.779 | -32.491 | -24.428 | -18.947 | -13.448 | -10.421 | -9.45 | -8.243 | -7.99 | -7.163 | -6.444 | -6.297 | -6.751 | -7.672 | -7.626 | -7.208 | -6.827 | -5.883 | -3.155 | -2.024 | -2.085 | -1.933 | -1.948 | -1.697 | -0.921 | -0.921 |
| Operating Income Ratio
| -0.871 | -0.916 | -1.372 | -1.075 | -1.393 | -0.069 | -2.286 | -2.52 | -4.54 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -3.459 | 0.33 | -0.864 | -0.757 | -6.053 | -2.102 | -5.523 | -2.369 | -1.397 | -1.343 | -1.368 | -1.476 | -1.437 | -1.416 | -1.42 | -1.247 | -0.548 | 0.007 | -0.379 | 0.139 | -0.314 | -0.219 | 0.102 | 0.015 | 0.001 | 2.673 | -0.646 | 0.207 | -0.334 | -0.323 | 0.474 | 0.013 | 0.015 | 0.017 | -0.094 | -2.273 | 0.166 | -0.078 | 0.125 | 1.444 | -1.208 | -1.208 |
| Income Before Tax
| -79.345 | -68.357 | -98.976 | -62.877 | -67.787 | -8.638 | -61.24 | -44.823 | -41.439 | -39.632 | -33.976 | -34.883 | -32.284 | -29.26 | -29.165 | -22.925 | -18.327 | -32.484 | -24.807 | -19.136 | -13.762 | -10.64 | -9.597 | -8.282 | -8.281 | -4.806 | -7.431 | -6.434 | -7.084 | -7.995 | -7.329 | -7.195 | -6.812 | -5.866 | -1.714 | -4.576 | -2.129 | -2.14 | -1.489 | -0.253 | -2.129 | -2.129 |
| Income Before Tax Ratio
| -0.91 | -0.911 | -1.384 | -1.088 | -1.452 | -0.091 | -2.513 | -2.661 | -4.698 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -3.601 | 0.678 | -0.617 | 2.58 | 5.523 | 2.411 | 1.397 | 1.343 | 1.368 | 0 | 0 | 0.263 | -0.008 | 0.545 | 0 | -0.005 | -0.005 | 0.467 | -0.011 | 0 | 0.217 | -0.217 | 0.281 | 0.315 | 0.207 | -0.207 | 0 | 0 | 0.642 | 0 | 0 | 0 | -1.442 | 2.552 | 0.045 | 0.129 | -0.334 | -1.697 | -1.208 | -1.208 |
| Net Income
| -79.345 | -68.357 | -98.651 | -62.199 | -67.17 | -11.218 | -66.763 | -47.234 | -42.836 | -40.976 | -33.976 | -34.883 | -32.284 | -29.26 | -29.165 | -22.925 | -18.327 | -32.484 | -24.807 | -19.136 | -13.762 | -10.64 | -9.597 | -8.282 | -8.281 | -4.806 | -7.431 | -6.434 | -7.084 | -7.995 | -7.329 | -7.195 | -6.812 | -5.866 | -1.714 | -4.576 | -2.129 | -2.14 | -1.489 | -0.253 | -2.129 | -2.129 |
| Net Income Ratio
| -0.91 | -0.911 | -1.379 | -1.076 | -1.438 | -0.119 | -2.739 | -2.804 | -4.857 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.67 | -1.44 | -2.08 | -1.32 | -1.54 | -0.26 | -1.54 | -1.13 | -1.1 | -1.07 | -0.9 | -0.93 | -0.86 | -0.78 | -0.78 | -0.61 | -0.49 | -0.88 | -0.71 | -0.56 | -0.41 | -0.32 | -0.32 | -0.31 | -0.32 | -0.19 | -0.31 | -0.27 | -0.3 | -0.41 | -0.38 | -0.38 | -0.36 | -0.31 | -0.12 | -0.26 | -0.17 | -0.17 | -0.12 | -0.02 | -0.27 | -0.27 |
| EPS Diluted
| -1.67 | -1.44 | -2.08 | -1.32 | -1.54 | -0.26 | -1.54 | -1.13 | -1.1 | -1.07 | -0.9 | -0.93 | -0.86 | -0.78 | -0.78 | -0.61 | -0.49 | -0.88 | -0.71 | -0.56 | -0.41 | -0.32 | -0.32 | -0.31 | -0.32 | -0.19 | -0.31 | -0.27 | -0.3 | -0.41 | -0.38 | -0.38 | -0.36 | -0.31 | -0.12 | -0.26 | -0.17 | -0.17 | -0.12 | -0.02 | -0.27 | -0.27 |
| EBITDA
| -74.033 | -66.856 | -117.71 | -62.12 | -57.415 | -4.964 | -53.7 | -40.491 | -38.769 | -37.977 | -32.608 | -33.107 | -30.57 | -27.573 | -27.691 | -21.127 | -17.773 | -32.491 | -24.428 | -18.798 | -13.448 | -10.41 | -9.45 | -8.013 | -7.99 | -7.151 | -6.444 | -6.08 | -6.74 | -7.662 | -7.151 | -7.202 | -6.824 | -5.881 | -3.061 | 0.25 | -2.25 | -1.933 | -2.073 | -1.697 | -1.208 | -1.208 |
| EBITDA Ratio
| -0.849 | -0.891 | -1.646 | -1.075 | -1.229 | -0.052 | -2.203 | -2.404 | -4.396 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |